The introduction of a 750 microgram teriparatide shot in Australia has created considerable attention within the medical community. Currently, its availability is limited, primarily via specialist doctors and registered centers. Distribution figures for this higher strength remain somewhat unavailable, but indications suggest a slow uptake due to t